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Avian paramyxovirus serotype-1 (APMV-1) is capable of infecting a wide range of avian species leading to a broad range of clinical
symptoms. Ease of transmission has allowed the virus to spread worldwide with varying degrees of virulence depending on the
virus strain and host species. Classiﬁcation systems have been designed to group isolates based on their genetic composition. The
genetic composition of the fusion gene cleavage site plays an important role in virulence. Presence of multiple basic amino acids at
the cleavage site allows enzymatic cleavage of the fusion protein enabling virulent viruses to spread systemically. Diagnostic tests,
includingvirusisolation,real-timereverse-transcriptionPCR,andsequencing,areusedtocharacterizethevirusandidentifyviru-
lentstrains.GeneticdiversitywithinAPMV-1demonstratestheneedforcontinualmonitoringforchangesthatmayariserequiring
modiﬁcations to the molecular assays to maintain their usefulness for diagnostic testing.
1.Introduction
Avian paramyxovirus serotype-1 (APMV-1) is a member of
theParamyxoviridaefamilyandisthecausativeagentofviru-
lent Newcastle disease (vND). The virus is able to infect all
orders of avian species, and virulent strains can cause signiﬁ-
cant clinical signs. Due to the extensive range of suscep-
tible hosts, the virus has been able to establish itself world-
wide.Infectionbyvirulentstrainshasresultedinseveralpan-
zootics since 1926 [1–3]. This disease can have devastating
eﬀectsonthepoultryindustryduetothehighmorbidity and
mortality associated with virulent strains of the virus [4–6].
Clinical signs of vND include drop in egg production, res-
piratory distress, listlessness, weakness, and central nervous
system symptoms [2]. Vaccination programs exist within the
United States (US), but the virus continues to replicate upon
infection and can spread from infected vaccinated ﬂocks.
Currently the US is free of vND, but introduction of the dis-
ease continues to be a major concern for the agricultural
community [2].
Illegal importation of infected birds is one of the major
modes of vND introduction into the US. Diagnostic testing
and rapid detection are important steps to prevent an out-
break of the disease. Real-time reverse transcription polym-
erase chain reaction (rRT-PCR) is a rapid diagnostic test for
detection of APMV-1 RNA. Virus isolation in embryonating
chicken eggs is the “gold standard” method of virus identiﬁ-
cation but can require 5 to 10 days to obtain an isolate. The
current United States Department of Agriculture- (USDA-)
validated rRT-PCR assay used at the National Veterinary Ser-
vices Laboratories (NVSL) is designed to detect the matrix
gene of most strains of APMV-1 [4, 7–10]. Studies have
shown that some strains of APMV-1 such as lineage 6 (Class
I) and some pigeon paramyxoviruses (PPMV-1) are not de-
tected by the primer/probe set used in this assay [7, 8].
ThematrixrRT-PCRassayisabletodetectAPMV-1RNA
within3hoursofsamplereceiptinthelaboratory.TheNVSL
uses this as an important screening assay allowing for a quick
turn-around time for reporting results. Lack of detection by
thematrixassaycanresultina7-to-14-daydelayinreporting
detection of the virus. Development of an rRT-PCR assay
that can detect a broad range of APMV-1 will increase the
diagnostic capability of the NVSL and the laboratories of2 Veterinary Medicine International
the National Animal Health Laboratory Network (NAHLN)
in the US.
When APMV-1 RNA is detected by the matrix rRT-PCR
assay, additional testing is required for that specimen to
determine if the RNA originated from a virulent strain. The
USDA-validated fusion gene rRT-PCR assay is a pathotyping
assay used to detect strains of vNDV. This assay allows for
rapid identiﬁcation of vNDV also within 3 hours of sample
receipt. The fusion gene rRT-PCR assay used at the NVSL
and the NAHLN laboratories is also limited in the strains of
vNDV that it is able to detect. Cormorant vNDV and most
strains of PPMV-1 are not detected using this fusion gene
assay [7, 11]. Although cormorant vNDV and PPMV-1 are
not highly infective to poultry, rapid detection is still impor-
tant in diagnosing APMV-1 infection. Development of an
rRT-PCR assay speciﬁc for these strains would allow labo-
ratories to easily distinguish cormorant vNDV or PPMV-1
from strains of vNDV that are highly contagious to poultry.
2. Classiﬁcation
There are 9 serotypes of avian paramyxovirus (APMV-1 to
APMV-9) capable of infecting avian species [2, 12–14]. New-
castle disease virus (NDV) falls into the avian paramyxovirus
serotype 1 (APMV-1). APMV-1 is a member of the order
mononegavirales in the Family Paramyxoviridae [2, 12,
15, 16]. This family is broken down into two subfamilies
the Paramyxovirinae and the Pneumovirinae. The paramyx-
ovirus family includes many signiﬁcant human and animal
pathogens that cause severe disease such as measles, mumps,
Hendra, Nipah, human respiratory syncytial virus, human
parainﬂuenza viruses 1–4, parainﬂuenza virus 5, Sendai vir-
us, and NDV infections. Rearrangement of the Paramyxovir-
idae family by the International Committee on the Taxon-
omy of Viruses in 1993 placed APMV-1 in the Rubulavirus
genus. Since that time diﬀerences among the Paramyxoviri-
dae family lead to development of a new Avulavirus genus.
TheParamyxovirinaeandPneumovirinaesubfamiliesdi-
ﬀer by several distinct characteristics. Morphologically,
pneumoviruses have narrower nucleocapsids and the ge-
nome encodes more proteins than paramyxoviruses [15–18].
Pneumoviruses encode a unique SH protein which is ex-
pressed as a type II integral membrane protein [15, 16]. The
protein locates to the plasma membrane and becomes pack-
aged as part of the envelope upon release of progeny virion.
These viruses also encode accessory proteins NS1 and NS2
along with two M2 matrix proteins which diﬀer from the
matrix protein of paramyxoviruses. Antigenic sites of para-
myxoviruses are capable of cross-reacting and are unique
from antigenic sites found on the surface of pneumoviruses
[17, 18]. The hemagglutinin-neuraminidase (HN) surface
glycoprotein protein of paramyxoviruses is capable of both
hemagglutination and neuraminidase activities, while the
surface glycoprotein (G) of pneumoviruses does not have the
neuraminidase function.
APMV-1 has a gene map structure similar to rubulavi-
ruses which is the reason for the initial classiﬁcation [15, 16].
Further analysis discovered that unlike other rubulaviruses,
APMV-1lacksaCprotein,asmallhydrophobic(SH)protein
and the phosphoprotein (P) is relatively small [15, 16, 19].
The intergenic region is also variable compared to other Ru-
bulaviruses. Some features such as nucleotide sequence iden-
tity at the conserved genomic termini and RNA editing make
it appear similar to Respiroviruses. The nucleotide sequence
doesnotalignwithRubulavirusesnorRespirovirusesleading
to the new classiﬁcation under the Avulavirus genus.
Two diﬀerent classiﬁcation schemes for NDV are used to
group isolates based on genetic analysis [6, 8, 14, 20, 21].
Diﬀerences in groupings arise between the two classiﬁcation
methods and either can be used based on preference. One
classiﬁcation proposed by Aldous et al. is based on genotypes
or genetic lineages grouped under serotype 1 (APMV-1)
[21]. This grouping scheme divides NDV into six lineages
(lineages1to6)[12].S ublineages(at od)w er ecr eat edinlin-
eages 3 and 4, while sublineages (a to e) were formed in lin-
eage 5. These genetic groupings are indicated by lineage and
sublineage such as 3a and 3b. A second classiﬁcation method
based on the genomic characterization and sequence analysis
of the F and L genes groups isolates into either Class I or
C l a s sI Ia so p p o s e dt ol i n e a g e s[ 4, 6, 8, 20, 22, 23]. Isolates
from Class I are present in the US Live Bird Markets, domes-
tic poultry, and wild waterfowl. Class I is composed of pri-
marily low virulent isolates, but one virulent isolate has been
included in that classiﬁcation. Class I viruses have a world-
wide distribution and are further divided into nine geno-
types. Isolates grouped in Class I have the longest APMV-1
genome at 15,198 nucleotides. Class I isolates are not usually
reported to OIE due to their low virulence designation.
Isolates causing all four panzootics from 1920 to the pre-
sent are classiﬁed as Class II [20]. Class II viruses are usually
recovered from poultry, pet birds, and wild waterfowl. Class
II viruses are further divided into genotypes I through IX.
Genotypes I through IV and IX have slightly shorter genome
lengths at 15,186 nucleotides. These genotypes are consider-
ed “early” due to their identiﬁcation between 1930 and 1960.
Genotypes V through VIII and X have a medium length ge-
nome at 15,192 and are considered “late” due to their identi-
ﬁcation after 1960. All vNDV are classiﬁed as Class II except
for one isolate which caused the Australian outbreak from
1998 to 2000. This isolate was determined to originate from
a low virulent strain of NDV (LoNDV) which increased in
pathogenicity after circulating through poultry [4, 6, 20].
This may explain the classiﬁcation in Class I where all other
isolates are LoNDV.
LaSota, B1, and Villegas-Glisson/University of Georgia
(VG/GA) vaccine virus strains are classiﬁed as Class II, geno-
type II [6, 23]. The velogenic neurotropic NDV (vnNDV)
Chicken/TexasGB/1948isalsoamemberofgenotypeIIindi-
cating the broad range of isolates which can be assigned to
one genotype. Genotypes V through VIII consist of only
vNDV isolates and have a worldwide distribution. The 1971
and 2002 California and 1971 and 1993 Florida outbreaks
were caused by genotype V [6, 11, 23]. Cormorant vNDV is
classiﬁedundergenotypeV,whilePPMV-1isclassiﬁedunder
subgenotypeVIb.AllotherClassIIgenotypesincludeviruses
isolated from outside of the US.Veterinary Medicine International 3
3.DiscoveryofAvianParamyxovirusSerotype-1
The virulent form of NDV was ﬁrst discovered in Java, In-
donesia, and Newcastleupon Tyneregion in England in 1926
[1–3, 20, 24]. Historical data indicate that outbreaks in poul-
try with symptoms similar to those seen with vND may have
been present in Korea prior to 1926 and also in Scotland as
early as 1896. According to Hanson, there are three hypothe-
ses to explain the sudden occurrence of vND in Southeast
Asia[25].First,itispossiblethatvNDwasendemicinSouth-
east Asia and only became a problem when poultry became
commercialized [1, 25]. The second theory is that vND was
present in bird species living in the tropical rain forest and
was introduced into poultry by man similar to the way the
movement of tropical birds spread the disease today. The
third explanation is that a major mutation occurred in the
precursor virus allowing for a change in pathogenicity from
low virulence to high virulence. Having the ability to infect
all orders of avian species, APMV-1 has been able to spread
throughout the world resulting in four panzootics [1, 4,
14, 26–28]. The initial panzootic took 20 years to develop
spreading very slowly throughout the world [1]. The United
States (US) was likely not involved in the ﬁrst panzootic but
was not so lucky during the second panzootic. The second
outbreak spread at a much faster rate, taking only 4 years to
spreadthroughouttheworld.Globalizationandthedevelop-
ment of various modes of transportation led to the increased
rate of disease spread during the second, third, and fourth
panzootics occurring in 1960, the late 1970s, and the 1980s,
respectively.
The term “Newcastle disease” was coined by Doyle as
a temporary name to distinguish it from other diseases at
the time [1, 2]. The name was never changed, but APMV-1
has become an alternative term used interchangeably with
NDV [4, 8]. Despite being a synonym for APMV-1, the term
“NDV” has recently evolved to describe the more virulent
formsofthediseasewhileAPMV-1encompassesallstrainsof
serotype 1 including asymptomatic, low virulent, and highly
virulent strains. Substantial evolution of APMV-1 led to the
formation of a separate clade of virulent NDV discovered in
2003 [11]. A virulent strain of NDV emerged between 1995
and 2000 aﬀecting Double-Crested Cormorants in Canada.
This strain causes signiﬁcant mortality in juvenile cormo-
rants and poses a risk to other avian species including poul-
try.
Pigeon paramyxovirus-1 (PPMV-1) is another strain of
APMV-1 which originated in pigeons [1, 3, 26]. This variant
of NDV was discovered in the Middle East during the third
panzootic in the 1970s. Like the NDV mentioned previously,
this disease has spread easily and now has a global distribu-
tion. In 1984 the virus spread from pigeons into domestic
poultry in Great Britain. Contamination of feedstuﬀsw i t h
pigeon feces led to 23 outbreaks in commercial chickens.
These outbreaks indicated the virus had the ability to repli-
cate and cause infection in other avian species. The disease
was no longer limited to feral pigeons and could be a source
ofeconomicloss.PPMV-1diseaseinpigeonshasbeenanon-
going panzootic since the 1980s [1,2].It remains an endemic
disease in several countries due to lack of vaccination, hous-
ing methods, and the sport of pigeon racing.
4. World Distribution
The World Organization for Animal Health (Oﬃce Interna-
tional des Epizooties, OIE) deﬁnes reportable NDV as an
APMV-1infectioninbirdswhichmeetsthefollowingcriteria
for determining virulence: the intracerebral pathogenicity
index (ICPI) in day-old chicks is greater than or equal to
0.7 or the carboxyl (C-) terminus of the F2 protein contains
multiple basic amino acids and phenylalanine at residue 117
of the F1 protein N-terminus [1–3, 7, 29, 30]. The presence
of at least three lysine or arginine residues between positions
113 and 116 deﬁnes the term “multiple basic amino acids.” It
is diﬃcult to track the geographic distribution of vND
throughout the world due to limited reporting to the OIE.
Some countries only report when the disease is present in
commercial poultry and not when it erupts in backyard
ﬂocks. Use of live vaccines can also interfere with the ability
to distinguish current infections with vaccinations in part
due to the variety of strains used in live virus vaccines.
Epizootics continue to occur on a regular basis in Cen-
tral and South America, Africa, and Asia, while sporadic epi-
zootics occur in Europe [1]. An increase in outbreaks in
Western Europe began in the 1990s. Several strains were
shown to be responsible for these outbreaks through phylo-
genetic and antigenic evaluations. Backyard poultry contin-
ues to be commonly infected in European countries includ-
ing outbreaks in 1991–1995 and 2000. The following out-
breaks occurred between 1995 and 1999: 18 in Denmark, 27
in Northern Ireland, two in Finland, one in Sweden, one in
the Republic of Ireland, and one in Norway. Several out-
breaks have occurred in Australia including one in 1932,
1998, 1999 and 2000. Of these outbreaks, the ones in the Re-
public of Ireland (1990) and in Australia (1998–2000) were
shown to originate from an increase in virulence from low
virulent ND to vND after replication in poultry [4, 6, 20].
In 2008 outbreaks were reported in the Dominican Republic,
Belize, Peru, Finland, Germany, and Japan [6]. Despite lack
of reporting to the OIE, NDV remains an endemic disease in
parts of Africa and Asia.
5. Outbreaksin the US
A disease termed “pneumoencephalitis,” serologically indis-
tinguishable from APMV-1, was discovered in the US in the
1930s [1, 2, 23]. As panzootics of the disease occurred, the
importation of caged and exotic birds into California caused
outbreaks in the 1970’s [1–3, 31]. Regulation of importing
birds has become strict, reducing the occurrence of the dis-
ease in the US. Despite importation quarantine procedures,
exotic birds are still smuggled into the country on a regular
basis. Virulent NDV is often isolated from illegally imported
and quarantined birds. In 1991 six states were aﬀected by
vND from illegally imported pet birds [2]. Fortunately the
disease was not transmitted to poultry during that outbreak.4 Veterinary Medicine International
The practice of ﬁghting cocks has also lead to the intro-
ductionofvNDintotheUS[2].In1975,1998and2002-2003
gamefowlweretoblameforthreeseparateoutbreaksofvND.
The 2002-2003 outbreak in California caused the most sig-
niﬁcant economic loss resulting in the depopulation of more
than 3 million birds on 2,671 premises including 21 com-
mercial table-egg layer ﬂocks [2, 23, 32]. Transportation of
infected birds or contaminated material and transmissibility
of the disease led to subsequent outbreaks in Nevada, Ari-
zona, and Texas. Eﬀorts to eradicate the disease cost the US
an estimated $180 to $360 million. Coordinated eradication
eﬀorts helped to end the outbreak by 2003. Since that time,
the US has been free of vND in poultry [4].
Currently low virulent strains of APMV-1 are endemic in
the US [4, 23]. A majority of the ﬁeld isolates are lentogenic,
but virulent strains of NDV cause outbreaks in double-crest-
edcormorants[2,3,11].Althoughadultcormorantsarecon-
sidered to be the natural reservoir for this strain of vNDV,
juvenile cormorants are highly susceptible to the disease. In
1990 and 1992 cormorant vND caused mortality events in
double-crested cormorants and pelicans. Isolates from epi-
demics in the north central US and southern California were
classiﬁed as velogenic neurotropic viruses, meaning these vi-
rulent strains caused clinical disease of the nervous system
[3]. Outbreaks have also occurred as recently as 2008 and
2010 [33]. These vNDV strains are usually restricted to cor-
morants, but in 1992 an outbreak of cormorant vND occurr-
ed in turkeys in North Dakota [2]. Reoccurrence of the dis-
ease in poultry has not been seen since that time. Cormorant
vNDV is reportable to the OIE due to the high ICPI values
and presence of multiple basic amino acids at the fusion gene
cleavage site [11]. All other virulent strains of NDV are con-
sideredexotictotheUSleadingtotheterm“exoticNewcastle
disease” (END) [6, 23, 27]. The California outbreak in 2002
was one example of the widespread use of the term “END.”
PPMV-1 was ﬁrst introduced into the US at the same
time as the Great Britain outbreak in 1984 [3, 26]. In the year
following the initial isolation in New York, the NVSL col-
lected 34 additional isolates of PPMV-1 primarily from the
eastern US. The virus spread throughout the US. and has
been isolated from feral and domestic pigeons since that
time.TexasandGeorgiaexperiencedasevereformofthedis-
ease in 1998, leading to concerns of an introduction into
commercial chickens similar to the outbreaks in Great
Britain. Up to this point, natural transmission of PPMV-1 to
domestic chickens has not occurred in the US. [3]. PPMV-1
continues to be endemic in feral and racing pigeons in the
US, and doves have also been shown to harbor the disease.
P i g e o n sh a v eb e c o m et h en a t u r a lr e s e r v o i rf o rP P M V - 1[ 11].
The Agricultural Bioterrorism Protection Act of 2002
established strict guidelines and procedures to control the
possession, use, and transfer of biological agents that pose
a threat to animal health [32, 34, 35]. All virulent strains of
Newcastle disease are List A biological agents classiﬁed as
Select Agents under the Code of Federal Regulations [6, 19,
32, 34]. Strict handling procedure must be followed when
working with this agent. Isolation or acquisition of vNDV
must be immediately reported to the Animal and Plant
Health Inspection Service (APHIS) and/or the Centers for
Disease Control and Prevention (CDC). In order to work
with vNDV in the US, a facility must be registered with
either the APHIS or CDC. Isolation of vNDV is reportable to
the OIE and can lead to international trade restrictions;
therefore, disease-free status is needed to maintain poultry
exports from the US [1, 3, 6, 8, 24].
6.ViralProteins
APMV-1 is an enveloped, pleomorphic, nonsegmented,
negative-sense, single-stranded RNA virus which is approx-
imately 15.2kb [2, 3, 15, 16, 36]. The genome encodes six
proteins including the nucleocapsid (NP), phosphoprotein
(P), matrix (M), fusion (F), hemagglutinin-neuraminidase
(HN),andtheRNA-dependentRNApolymerase(L).Thevi-
rion is composed of a stable nucleocapsid core consisting of
the NP protein bound to the genomic and antigenomic RNA
[14–16, 37, 38]. The P and L proteins bind to the nucleocap-
sid core shortly after synthesis to form the ribonucleoprotein
(RNP) complex. This RNP complex becomes the template
for transcription by the RNA-dependent RNA polymerase L
protein. The L protein binds the genomic RNA at a 3  entry
site in the RNP complex and transcribes the six protein genes
using a start-stop mechanism. In this mechanism the L pro-
tein initiates transcription and releases the RNP complex
after transcribing a number of nucleotides along the gene
whichfortheParamyxoviridaefamilyisalwaysequaltosome
multiple of six nucleotides. This transcription requirement is
referred to as the “rule of six” [14, 37].
Transcription creates a gradient of messenger RNA
(mRNA)proteintranscriptsinorderfromthe3 -NP-P-M-F-
HN-L-5 . Protein gene proximity to the 3  end results in a
higher production of the protein. The Paramyxovirinae sub-
family requires the genome length to be a multiple of six
nucleotides for eﬃcient replication. The NP subunit must be
in contact with six nucleotides at a time which is termed the
“rule of six” [14, 37]. A shift in the NP subunit on the ge-
nomic or antigenomic RNA results in a shift in the promoter
position leading to incorrect or ineﬃcient replication.
The ND virion contains two types of surface glycopro-
teins, the F protein and the HN protein [2, 15, 16, 38–43].
T h eFp r o t e i ni sac l a s sIf u s i o ng l y c o p r o t e i nw h i c hi ss y n -
thesized as a type I integral membrane protein. When the
protein is translated, three identical polypeptide chains as-
semble into homotrimers. Carbohydrate chains are post-
translationally added to the homotrimers which are biolog-
ically inactive. Host proteases must cleave the precursor pro-
tein in order for it to become biologically active.
The F protein cleavage site of velogenic and mesogenic
strains (including PPMV-1 and cormorant vNDV) contains
afurinrecognitionsitewithmultiplebasicaminoacids(argi-
nine or lysine) surrounding the glutamine at position 114
(C-terminus of F2 subunit) and a phenylalanine at position
117 (N-terminus of F1 subunit) [2, 15, 16, 40, 42, 43]. Eﬃ-
cient cleavage of the F0 protein and virulence of the NDV
strain are reliant on the presence of one or both arginines at
positions 112 and 115 and/or the phenylalanine at position
117. Hostubiquitousintracellularproteasesareableto cleaveVeterinary Medicine International 5
the F protein in the trans-Golgi membranes due to the pres-
enceofthepolybasicaminoacids.Uponarrivalattheplasma
membrane, these F proteins are already in the active state.
After activation the homotrimers are transported via exocy-
tosis to the viral surface. The C-terminal region creates the
transmembrane domain which anchors the protein in the
plasma membrane while the globular head containing the
fusion peptide extends from the surface of the plasma mem-
brane into the extracellular space to initiate fusion with the
host cell membrane. Low virulent strains do not have multi-
ple basic amino acids in the F protein cleavage site. Instead
they have single basic amino acids and a leucine at position
117. Due to these diﬀerences the F proteins are not cleaved at
the trans-Golgi membranes like they are in vNDV and
mNDV strains. The F proteins remain in the inactive state
when they reach the plasma membrane.
Synthesis of the F protein occurs along the ER as an in-
activeF0 precursor[42,44].ToactivatetheFprotein,F0 must
be cleaved to functional F2 and F1polypeptides to enable in-
fectivity of progeny virions. These polypeptides must remain
bound to the viral surface by disulﬁde bonds enabling the
virus particles to be infectious. The two hydrophobic regions
of the F1 polypeptide are the N-terminal fusion peptide and
the transmembrane domain. The F1 polypeptide also con-
tains two heptad hydrophobic repeat regions designated
HRA and HRB.
Upon initial translation the F protein folds into a meta-
stable form prior to fusion [42, 44]. Large scale conforma-
tional changes occur once fusion is activated. These confor-
mational changes progress down an energy gradient to form
a stable postfusion conformation. Active F1 polypeptide me-
diates fusion between the viral lipid membrane and host cel-
lular membrane. Membrane fusion allows the viral genome
to enter the host cell where initiation of viral replication oc-
curs.
The second surface glycoprotein is a type II integral
membrane, protein. The HN protein has a transmembrane
region which, unlike the F protein, is located at the amino-
terminalregionoftheprotein[42,44].Ahydrophobicregion
about 25 amino acids in length anchors the protein in the
viral membrane and acts as a signal sequence. The HN pro-
tein promotes fusion of the viral and host cell membranes
through interaction with the F protein [45, 46]. It is able to
hemagglutinate cells by binding to sialic acid (SA) receptors
[42,44,45].Theneuraminidase oftheHNproteincancleave
SA structures for viral release after replication. The HN pro-
tein has also been shown to play a role in tissue tropism in-
dependent of the amino acid sequence of the F protein [45].
Replication of NDV begins by attachment of the virus to
the host cell membrane. The HN protein binds to the SA re-
ceptors on the surface of the cell membrane bringing the F
protein closer to the host cell [42, 44, 45]. The HN inter-
action with SA receptors is thought to initiate the conforma-
tional changes needed to activate the F protein. Figure 1 is
amodelprovidedbyBissonnetteetal.,describingmembrane
fusion events [44]. During fusion events the F1 polypeptide
undergoes additional conformational changes which expose
the HRA and HRB regions [42, 44]. The two hydropho-
bic regions of the F1 polypeptide act to bind the viral
membrane to the host cell membrane. The N-terminal fu-
sion peptide attaches to the host cell membrane, while the
transmembrane domain anchors the viral membrane. A 6-
helix bundle (6HB) couples the free energy released during
protein refolding when the two membranes merge. The ﬁnal
conformational state of the F protein is the most stable form
and is not reversible [44].
Membrane fusion occurs at neutral pH, but the exact
mechanism of fusion activation is unknown [38, 39, 42, 47,
48]. The accepted steps during the fusion event begin with
docking of the viral membrane to the host cellular mem-
brane. This docking event occurs through interaction bet-
ween the HN protein and SA receptors. The F protein is acti-
vated as the membranes approach, and upon membrane
merging a pore is formed between the membranes [38, 39,
43, 48–50].
TheFproteinaloneisnotsuﬃcientformembranefusion
to occur [38, 39, 43, 46, 48–50]. Coexpression of the HN at-
tachment protein was originally thought to be required to
promote fusion. Attachment of the HN protein to the SA
receptors may not be necessary to initiate activation of the F
protein. NDV isolates that have mutations in the attachment
function of the HN protein have been shown to continue to
promote fusion. It has also been shown that lack of co-ex-
pression of the HN protein allows for fusion events to occur
with some F proteins. The attachment event itself may not
support the activation of the fusion process. NDV HN mu-
tants have been shown to be unable to promote fusion while
theattachmentfunctionremainsintact.Theattachmentpro-
tein must be from the same virus as the fusion protein in or-
der for fusion events to occur [38, 39, 43, 48–50].
The NP, P, and L proteins also play a role in replication
and infectivity. All three proteins are required for viral syn-
thesis[15–18].TheNPproteinservesasthesiteforviralRNA
synthesis and captures the genomic RNA into the nucleo-
capsid during replication to protect it from degradation. The
concentration of free NP protein within the cell plays a role
in restricting the rate of transcription and replication. The
P and L proteins are nucleocapsid-associated proteins and
are needed for polymerase activity. The P protein is directly
involvedinnascentchainassemblyandbindstheLproteinto
the NP-bound template RNA to form the RNP complex.
V i r a lr e p l i c a t i o nr e l i e so na l lt h r e ep r o t e i n st op r o d u c ei n f e c -
tive virus particles.
7. Viral Replication
Fusion events result in pore formation allowing the viral nu-
cleocapsid complex to enter the host cell [2, 38, 43, 48–50].
All viral replication events occur within the host cell cyto-
plasm. Because the genome is negative-sense RNA, the RNA-
dependent RNA polymerase (L) is required to enter the cell
with the genomic RNA in order for transcription to occur.
Positive-sense RNA intermediates are formed which act as
mRNA using the host cell translation machinery to translate
proteins. Viral proteins are transported to the cell membrane
forvirionformation.Thehostcellmembranebecomesmod-
iﬁed to form the new viral envelope. The nucleocapsid6 Veterinary Medicine International
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Figure 1: (a) The prefusion form of F contains a globular head with the HRA region in 11 distinct sections, and the HRB region is in a three-
helix bundle. The F TM domain is also represented as a three-helix bundle, consistent with the oxidative cross-linking data. (b) Upon HN
binding to target cells (HN not shown for clarity), F is activated for fusion, and the HRB region separates, forming the open-stalk conforma-
tion where N-1 peptide can bind to HRB. At this open-stalk stage, the TM domain is still thought to be in a three-helix bundle because
N-1-HAt can still bind to HRB after the addition of the oxidative cross-linker. (c) After formation of the open-stalk conformation, HRA re-
arranges to form the extended α-helical bundle, and the FP is inserted into the target cell membrane (the prehairpin intermediate). (d-e)
Finally, the postfusion state occurs with the formation of the 6-HB. (d-e and f–i) Lipid intermediates in fusion with the F protein, removed
for clarity. The two bilayers contain an inner and outer leaﬂets and are separated by the extracellular space. During the process of F refolding
to form the postfusion form, water is excluded from the extracellular space and the outer leaﬂets initially merge to form the lipid stalk inter-
mediate. The lipids of the bilayers mix, forming the hemifusion intermediate, and then the fusion pore forms. F domains: FP (red), HRA
(green), globular head (yellow), HRB (blue), TM domain (orange), cytoplasmic tail (pink). (From Bissonnette et al., 2009 [44]wi t hp e r m i s -
sion.)
proteins align within the new membrane to form the RNP
complex. The new virus particles are released by budding
through the host cell membrane. During viral assembly viral
glycoproteins may be expressed on the surface of the host cell
membrane. Accumulation of the F protein and HN attach-
ment protein on surface of infected cells initiates fusion bet-
ween neighboring cells to form syncytia [43, 44, 48]. The F
protein has been shown to be capable of initiating syncytia
formation without the aid of the HN protein [44, 48].
8. Transmission
The primary route of transmission is either by ingestion of
fecal contaminated material or inhalation of droplets con-
taining the organism [1–3, 24, 51]. Viral replication in the
respiratory tract of infected birds allows for dissemination of
the virus during nasal discharge. When the virus reaches the
mucous membranes of susceptible birds, the virus is likely to
reach the upper respiratory tract. Replication in the respira-
tory tract of newly infected birds allows for the potential to
expose more susceptible birds and the virus easily spreads
through the ﬂock. The success of this mode of transmission
hinges on the environment temperature and humidity and
the viral load contained in the aerosolized droplets. Out-
breaks in England from 1970 to 1971 and Northern Ireland
in 1973 were attributed to respiratory inhalation of contami-
nateddroplets.Thevirusisalsoabletoreplicateintheintest-
inal tract which can then be excreted in the feces. It has been
shown that large amounts of virus are commonly excreted in
the feces of NDV-infected birds.
Several methods of virus transmission have been linked
to the introduction of NDV to new premises. Direct inges-
tion of feed or water contaminated with feces delivers a high
virus load to susceptible birds [1, 2, 24]. This was demon-
strated by the PPMV-1 transmission to chickens that occurr-
ed in Great Britain in 1984. Importation of sick pet or exotic
birds, movement of commercial poultry and game birds or
the sport of racing pigeons allows for dissemination of the
virus across vast distances. A broad range of animals includ-
ing reptiles and humans can be infected with NDV and are
able to distribute the virus to other vulnerable animals. The
virus particles have been shown to enter the eggshell after it
hasbeenlaidwhichgivesrisetothepotentialforvirusspread
during transport of table or hatching eggs. Live or attenuated
vaccines may also be a source of infection if the virus used to
prepare the vaccine is not properly killed or the vaccine is
contaminated. Vaccination and insemination crews as well as
veterinarians have been shown to transmit the disease from
farm to farm due to improper cleaning and disinfecting of
equipment.Veterinary Medicine International 7
Live bird markets can also contribute to the persistence
andspreadofthevirus.Thesemarketsmaynotfollowappro-
priate cleaning and disinfecting techniques which allows for
the possibility of environmental contamination. Live birds in
the market are exposed to birds from multiple sources. These
birds run the risk of disseminating the virus as they leave
the market. Low virulent strains of NDV have been regularly
isolated from wild birds by the NVSL [52]. Migratory wild
birds have been shown to transmit NDV to free range poul-
try through direct contact or by contamination of feed or
water [1, 2]. In 1997, eleven outbreaks of NDV in poultry in
Great Britain were linked to movement of wild birds.
Double-crested cormorants have also been blamed for the
spreadofcormorantvNDtonewpremisesduringmigration.
The virus is able to persist in adult cormorants as the natural
reservoir allowing epidemics to occur in ﬂedgling cormo-
rants which are highly susceptible to this strain of NDV
[2, 33].
Biosecurity of commercial poultry facilities is an impor-
tant step in preventing transmission of NDV and large eco-
nomic loss. It is recommended that poultry farms and hatch-
eries should not be in close proximity to each other to pro-
tect highly susceptible young birds [1]. Poultry farms and
ﬂock houses should also be spread apart from each other to
avoid transfer of contaminated material between premises.
Movement of equipment and materials between farms
should be restricted and subject to thorough cleaning and
disinfecting. Humans may also harbor the virus in the con-
junctival sac resulting in conjunctivitis and possible dis-
semination of the virus [1, 24, 51]. It is not advised for
people to move between premises unless appropriate biose-
curity procedures are followed. Separation of farms based on
species is important to prevent introduction of exotic dis-
eases to new avian species. The water supply should be clean
and should not come from surface water where migratory
birds have the potential to contaminate the water source.
9. Pathogenesis
The pathogenicity of the virus depends on multiple factors
including host species, age, immune status, secondary infec-
tions, stress, environmental conditions, the amount of virus
transmitted, and the route of transmission but most impor-
tantly the strain of the infecting virus [1, 2]. Chickens are
more susceptible than other species, while ducks tend to
show no clinical symptoms; thus, waterfowl are considered
a natural reservoir for NDV. Cleavage of the F protein during
viral replication in the host plays a major role in the viru-
lence of the virus [1, 2, 40, 48, 53]. Velogenic and mesogenic
strains of NDV are able to replicate systemically due to the
active state of the F protein. Unfortunately vNDV and
mNDV,strainscannotbediﬀerentiatedbasedontheiramino
acid sequences at the F protein cleavage site. Due to the lack
of multiple basic amino acids in low virulent strains, the F
protein must be cleaved by secretory trypsin-like proteases
which are limited to the mucosal membranes in the respira-
tory and gastrointestinal tracts. Low virulent strains are not
able to replicate systemically due to the limited availability of
these trypsin-like proteases. Examples of vNDV, mNDV and
LoNDV cleavage site sequences are shown in Table 1.
ThelengthoftheHNproteinhasbeenshowntoinﬂuence
pathogenicity as well [13, 41]. The HN0 precursor protein
is composed of 616 amino acid residues in avirulent strains
of NDV including Ulster and D26 [41]. This inactive HN0 is
converted to an active protein by proteolytic cleavage of a few
nucleotides at the C-terminus. The open reading frame of
other NDV strains includes stop codons upstream resulting
in active proteins of 571 and 577 amino acids in length.
Shortening of the HN active protein plays some role in viru-
lence but is not completely understood.
Upon infection with NDV, macrophages of the immune
s y s t e mo fc h i c k e n sp r o d u c et y p eIa n dt y p eI Ii n t e r f e r o n
(IFN) [3]. Ten genes encode chicken type I IFN (ChIFN1)
while only one gene is responsible for chicken type II IFN
(ChIFN2). NDV is able to replicate in these macrophages
despite the immune system response. Peripheral blood lym-
phocytes and heterophils induce apoptosis when infected
with the virus. Macrophages of the respiratory system of
turkeysinfectedwithNDVshowreductioninphagocyticand
bacteriocidal abilities [3]. Natural immune stimulation in
poultry may not be suﬃcient to control the disease depend-
ing on the infecting strain. Control strategies are needed to
prevent development of severe disease.
10.ClinicalSigns
Theincubation period fromthetime of infectiontodevelop-
mentofdiseasevariesfrom2to15daysdependingonseveral
factors [2, 12]. The pathogenicity of the virus, host species
and age, host immune status, secondary infections, stress,
environmental conditions, the amount of virus transmitted,
and the route of transmission can all play a role in determin-
ing the severity of disease and the length of incubation. Dis-
ease severity has led to classiﬁcation of NDV isolates under
threedistinctpathotypes[1–3,12,53–55].Infectionoflento-
genic NDV isolates can range from nonapparent to mild res-
piratory or gastrointestinal disease in adult chickens. When
replication is limited to the gastrointestinal tract, the infec-
tion is often classiﬁed as asymptomatic enteric due to lack of
respiratory symptoms. Young susceptible birds may develop
a more serious respiratory disease that can lead to death due
toincreasedsusceptibilitytosecondaryinfection.LoNDVare
categorized as lentogenic NDV and are commonly used as
sources for vaccine production. Mesogenic (mNDV) isolates
are considered of intermediate virulence. Infection is typical-
lysystemicandcanleadtodevelopmentofanonfatalrespira-
tory disease. Drop in egg production can be seen in layers in-
fected with mNDV. Rarely symptoms of the nervous system
can develop, but mortality is usually low following infection.
PigeonparamyxovirusisolatesusuallyfallinthemNDVclas-
siﬁcation due to their intermediate virulence and neurologic
symptoms.
Highlyvirulentvelogenic(vND)virusesarealsosystemic
and can cause high morbidity and mortality. Factors such as
species of the infected bird, age, coinfection with other
organisms, route of exposure, viral dose, stress, and8 Veterinary Medicine International
Table 1: Examples of ICPI, MDT, IVPI, and cleavage site for some strains of NDV.
APMV-1 Strain Pathotype ICPI MDT IVPI Cleavage site
sequence
Ulster 2C Asymptomatic enteric 0.0 >150 0.0 112G-K-Q-G-R-L117
Queensland V4 Asymptomatic enteric 0.0 >150 0.0 112G-K-Q-G-R-L117
Hitchner B1 Lentogenic 0.2 120 0.0 112G-R-Q-G-R-L117
NJ-LaSota Lentogenic 0.4 103 0.0 112G-R-Q-G-R-L117
NJ-Roakin
(Daubney) Mesogenic 1.45 68 0.0 112R-R-Q-K-R-F117
Beaudette C Mesogenic 1.6 62 1.45 112R-R-Q-K-R-F117
Texas Gilbert Boney
1948 Velogenic neurotropic 1.75 55 2.7 112R-R-Q-K-R-F117
Italian Velogenic 1.85 50 2.8 112R-R-Q-R-R-F117
England-Herts- 33/56 Velogenic 2.0 48 2.7 112R-R-Q-R-R-F117
∗Information obtained from Diseases of Poultry 12 Ed. Tables 3.2, page 81 and 3.4, page 87, Liu (2009) et al. [22], and from NVSL.
the immune status of the individual determine disease sever-
ity [2, 12]. Velogenic viscerotropic ND (vvND) causes acute
infection of the gastrointestinal mucosa resulting in hemor-
rhagic lesions and death [1, 2, 12, 30]. Clinical signs may
begin with weakness, increased rate of breathing, listlessness,
and prostration. During course of infection, green diarrhea,
muscular tremors, and paralysis of the extremities may be
apparent. Edema may be seen on the head especially around
theeyes.Inhighlysusceptibleﬂocks,mortalitycanbeashigh
as 100%.
Velogenic neurotropic NDV (vnNDV) isolates do not re-
plicate in the gastrointestinal mucosa like vvNDV [1, 2, 12,
30]. Infection primarily leads to respiratory distress followed
by neurologic disease. Drop in egg production is also seen
with this strain of vNDV. Morbidity is similar to vvND,
around 100%, but the mortality rate is lower. Mortality in
adult birds is usually only 50%, but in young chickens it can
be as high as 90%. Cormorant vNDV falls within the vnNDV
classiﬁcation due to the severe neurologic symptoms and
high mortality rate in juvenile cormorants [3]. Clinical
symptoms in turkeys may be less severe than those seen in
chickens. Game birds are also susceptible, and outbreaks oc-
casionally occur in these species. Ratites are less susceptible
to disease development, while waterfowl are usually resistant
[1, 2, 12].
11. Vaccination
Vaccination for NDV originated with the use of inactivated
infective strains which were shown to provide protection in
chickens [2, 3]. Inability to produce safe and eﬀective vac-
cines resulted in discontinuation of large-scale production.
TheabilitytoattenuatevNDV,developedbyIyerandDobson
in 1930, enabled mNDV vaccine development [2]. Inacti-
vated vaccines were also relied upon in the US when NDV
was ﬁrst introduced in the 1930’s [2, 3]. Inactivated vaccines
involved adsorbing the virus to aluminum hydroxide. These
t y p e so fv a c c i n e sw e r ec o m m o n l yu s e di nE u r o p eu n t i lt h e
thirdpanzooticinthe1970’s.Theperformanceofinactivated
vaccines was not suﬃcient during that panzootic so vaccina-
tion programs implemented the use of live vaccines. Meso-
genic Roakin and milder Hitchner B1 and LaSota strains
were developed into live virus vaccines and continue to be
usedtoday toproduceliveandinactivatedvaccines[1,2,30].
Modern inactivated vaccines utilize oil emulsions instead of
aluminum hydroxide resulting in more successful vaccines.
Oil emulsions act as adjuvants to stimulate the inﬂammatory
immune response [39]. Inactivated vaccines lacking an adju-
vant will not induce the early immune response needed to
stimulate antibody production. The adjuvant is needed to
present the antigen to the immune system, localize the anti-
gen to the inoculation site, or directly stimulate the innate
immune response. Aluminum hydroxide deposits the anti-
gen at the site of inoculation, while oil emulsions stimulate
the immune response directly.
Vaccination for NDV is practiced widely in the US, and
like other countries vaccine production is tightly controlled
[2, 6]. OIE guidelines for vaccine production specify that live
and inactivated virus vaccines must be tested extensively [2,
30].ThemasterseedsoflivevirusvaccinesmusthaveanICPI
valuelessthan0.4ifnolessthan107 50%meanegginfectious
dose (EID50) is inoculated in each bird or less than 0.5 if no
less than 108 EID50 are inoculated in each bird. Similarly the
master seeds of inactivated viruses must have an ICPI value
less than 0.7 if no less than 108 EID50 are inoculated in each
bird.
Live virus vaccines may be divided into lentogenic and
mesogenic groups [1, 2, 30]. The immune response has been
shown to increase as the pathogenicity of the live virus vac-
cine increases. To provide the best protection vaccine pro-
grams have adopted the method of progressive vaccinations
which involves successive booster vaccines with increasingly
virulent strains [1, 2, 30]. Another method begins with low
virulentlivevirusvaccinationfollowedbysuccessivevaccina-
tions using more virulent inactivated viruses [1, 2, 30]. This
method of combining inactivated and live virus vaccines
leads to stimulation of the cell-mediated, innate, and hu-
moral immune responses to improve protection. Live virus
vaccines are usually lyophilized allantoic ﬂuid produced byVeterinary Medicine International 9
infecting embryonating chicken eggs. The advantages of live
vaccines include ease of administration, inexpensive produc-
tion, and ease of application. Live virus stimulates a cell-
mediated immune reaction which results in rapid protection
after vaccination. Live viruses are able to transmit between
birds so protection can be spread easily among a ﬂock. This
alsoresultsindisadvantagesduetothepotentialforlivevirus
vaccines to produce clinical symptoms in the ﬂock which are
againeasilytransmitted.Maternalantibodiescanpreventlive
virus vaccines from immunizing young birds. Cell-mediated
immune response initiated byinfection bylive virusdoes not
oﬀer complete protection against challenge. This oﬀers an
additional disadvantage for live virus vaccines.
Lentogenic live virus vaccines are administered by intra-
nasal inoculation, eye drop, or beak dipping [2, 3, 30, 51].
Administrationofmesogeniclivevirusvaccinesismorelabor
intensive and includes wing-web stabbing or intramuscular
inoculation. Addition of controlled concentrations of vac-
cines to drinking water is a popular method of vaccination.
Sprays and aerosols are also a popular method for vaccine
application, butthe size of aerosol particles must be controll-
ed to allow for proper inhalation. This method is usually re-
served for secondary doses of vaccines to avoid severe reac-
tions. Suboptimal vaccinations can result in “rolling reac-
tions” where ND may cause disease that spreads between the
birds of a ﬂock resulting in increasing respiratory disease [6].
It is also possible that introduction of LoND from wild birds
into a suboptimally vaccinated ﬂock may result in the same
“rolling reaction.”
Inactivatedvaccinesareproducedusingthesamemethod
as live virus vaccines, but the virus in the allantoic ﬂuid is
inactivated using beta-propiolactone or formalin [2, 3, 30].
An adjuvant (originally aluminum hydroxide and now oil
emulsion) is added to the inactivated virus to stimulate the
immune system. Several viruses are currently used to pro-
duce inactivated vaccines including Ulster 2C, Hitchner B1,
LaSota, Queensland/V4, F, and Roakin [2, 3, 20, 30]. Admin-
istration of inactivated vaccines is limited to intramuscular
or subcutaneous injection. Storage of inactivated vaccines is
easier than live virus vaccines since the viability of the virus
does not have to be maintained. It is labor intensive to pro-
duce inactivated vaccines due to the steps required for inacti-
vation and testing to ensure inactivation was complete. Oil-
emulsion inactivated vaccines can be used in day-old chicks
becausethematernalantibodiesdonotaﬀectthevaccineeﬃ-
ciency.Thereisa42-daywithdrawalperiodbetweenvaccina-
tion and slaughter for human consumption in the US that
poses a problem for broiler chickens due to their short life-
span. No matter which type of vaccine is used, birds are still
abletobecomeinfectedbyNDVandcantransmitthedisease
to others [2, 5, 6]. Because vaccination cannot prevent dis-
ease transmission, its role is limited to safeguarding the indi-
vidual bird from signiﬁcant disease by providing protective
antibodies that can quickly respond to the introduction of
an ND virus [2, 5, 6].
The F and HN surface glycoproteins can elicit a protec-
tive humoral immune response [3, 5, 30, 39, 51]. Many re-
searchers are using recombinant viruses to express these pro-
teins for vaccine production. Fowlpox, vaccinia, pigeon pox,
Marek’s disease virus, retrovirus, and baculovirus have all
been used as recombinant vectors to express the F and HN
proteins [3]. A recombinant herpes virus expressing the F
and HN proteins has been successful in protecting turkeys.
Sakaguchi et al. expressed the F protein of lentogenic D26
using a recombinant Marek’s disease virus [5, 56]. Mori et al.
used a recombinant baculovirus to express the F protein of
D26,andLeeetal.usedarecombinantbaculovirustoexpress
both the F and HN proteins of LaSota and vvNDV Kr-005/00
[5, 57]. These subunit marker vaccines can provide eﬀective
antibody production while lending the ability to distinguish
between natural NDV infection and vaccination [5, 20]. Re-
search is emerging on the development of genotype and
antigenically matched vaccines which are meant to eliminate
viral shedding upon infection with a strain of the same geno-
type or antigenic characteristics [6]. Naked DNA plasmids
are also being developed to express the F protein for vac-
cination [3].
Vaccination may cause selective pressure leading to the
appearance of new strains of NDV [6, 23]. Mexico and Re-
public of Korea are experiencing the eﬀects of selective pres-
sureorineﬀectivevaccination.Bothcountrieshavecontinual
outbreaks of vND in backyard ﬂocks and have well-vaccinat-
edbirdswithhighlevelsofprotectiveantibodiesthatdevelop
a drop in egg production with the absence of clinical symp-
toms. Vaccination against PPMV-1 in racing pigeons is a
common practice in many countries. Exposure to unvacci-
nated feral pigeons opens the possibility of disease transmis-
sion.
12. Diagnosis/Control
12.1. Signs/Symptoms. Diagnosis of disease begins with eval-
uationofclinicalsignsandsymptoms.Inchickenssymptoms
indicative of vND include prostration, ruﬄing of feathers,
depression, leg and wing paralysis, or other neurologic signs
along with high mortality reaching 100% in fully susceptible
ﬂocks [1, 2, 12]. Clinical symptoms in the ﬁeld may not be
a reliable measure of the virulence of the virus. Laboratory
diagnosis is necessary for conﬁrmation and pathotyping of
NDV to rule out other diseases which may cause similar
symptomsincludinghighlypathogenicavianinﬂuenzavirus.
12.2. Pathology. As previously mentioned the strain and the
route of infection play a large role in development of clinical
symptoms and lesions. Infection with panzootic vvND is
commonly associated with necrosis of the intestinal wall or
lymphoid tissues resulting in hemorrhagic lesions in the mu-
cosa of the proventriculus, ceca, duodenum, jejunum, and
ileum [1, 2, 12, 51]. Birds displaying neurologic symptoms
do not have pathologic lesions in the central nervous system.
Gross lesions of the respiratory tract may include hemor-
rhage of the respiratory mucosa, airsacculitis and congestion
of the trachea but are not always seen. Secondary bacterial
infection is a signiﬁcant concern and may lead to thickened
air sacs with catarrhal or caseous exudates. Infection in other
o r g a n sm a yb em a r k e db yh e m o r r h a g ei nt h el o w e rc o n j u n c -
tiva, paratracheal edema, and necrosis of the spleen. Laying10 Veterinary Medicine International
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generative ovarian follicles, hemorrhage of reproductive or-
gans including the ovarian follicles and egg yolk in the ab-
dominal cavity [1, 2, 12].
Examination by histopathology also yields a variety of
descriptive lesions inﬂuenced by the virulence of the strain
and route of introduction. Microscopic lesions may include
cellular inﬁltration, oedema, hyperaemia, and necrosis. Neu-
rologic lesions are comprised of encephalomyelitis with de-
generation of the neurons, lymphocyte inﬁltration, and hy-
pertrophic endothelial cells. These lesions are usually found
in the cerebellum, midbrain, spinal cord, medulla, and brain
stem. Complete loss of cilia in the respiratory tract can occur
within days of infection. In the early stages of infection,
lymphocyte and macrophage inﬁltration is common in the
mucosa of the upper respiratory tract along with congestion
and edema.
Virulent strains can cause hemorrhages of the blood
vessels in multiple organs especially the intestinal tract. The
serosal and mucosal surfaces show marked necrosis in intes-
tinal lymphoid aggregates. Necrosis can be seen in the cecal
tonsils, and hyperplasia of monocytes is evident in the liver
and other organs. The germinal centers of the spleen and
thymus show marked focal vacuolation and lymphocyte des-
truction. Hemorrhages can also occur in the heart, gallblad-
der, skin, and eyelids leading to conjunctivitis. Petechiae of
the wattle and combs and facial edema are commonly seen
during infection. Diagnosis should not be based on pathog-
nomonic lesions or clinical signs because these types of
symptoms and lesions are not speciﬁc to any strain of NDV.
Some lesions may be seen with infection of low virulent
strains, and symptoms may be similar to those seen with
more virulent strains. Pathology is a useful tool to guide dis-
ease diagnosis, but it cannot be used solely to diagnose ND
considering these types of lesions are not unique to NDV in-
fection.
12.3.SerologicTechniques. Detectionofantibodyisprimarily
used to evaluate the immune response to past infection or
vaccination [1, 2, 12, 30, 51]. Generally a higher antibody
titer will be seen following a more recent infection. Several
diagnostictestsareavailableincludingvirusneutralizationin
chick embryos, plaque neutralization, hemagglutination-in-
hibition (HI), single radial immunodiﬀusion, agar gel im-
munodiﬀusion(AGID),andenzyme-linkedimmunosorbent
assay(ELISA).TheELISAandHItestsarecapableofmeasur-
ing titers. The ELISA consists of a microtiter plate that has
NDV antigen attached to the bottom of each well. Addition
of serum containing anti-NDV antibodies creates antigen-
antibody binding which is detected using antibodies pro-
duced in another species against chicken antibodies. An
enzyme is conjugated to the anti-chicken antibodies so when
anti-NDV antibodies are present and bound to the NDV
antigen, the enzyme bound to the anti-chicken antibodies
catalyzes a color change in the well. This can be read by view-
ing the plate or quantitatively using a spectrophotometer.
Serial dilution of the anti-NDV antibody test serum can be
used to determine the titer.
The HI test is also performed in a microtiter plate [12,
30, 58]. The OIE standard HI method employs a V-bottom
microtiter plate in which serum test specimens are serially
diluted in twofold dilutions using phosphate buﬀered saline
(PBS). A known quantity of NDV antigen (usually 4 Hemag-
glutinating Units) is added to each well and incubated to
allow antigen-antibody binding. A 1% suspension of red
bloodcells(RBCs)isaddedtoeachwellandincubatedagain.
The hemagglutinin protein on the envelope of NDV binds
RBC’s resulting in what is referred to as hemagglutination.
Unbound antigen in the HI test is able to hemagglutinate the
RBC’sintheabsenceofanti-NDVantibodyresultinginadif-
fuse red color throughout the well. In the presence of anti-
NDV antibody, the antigen is not allowed to hemagglutinate
theRBC’sbecausethehemagglutininproteinisboundtoand
blocked by the anti-NDV antibody. The RBC’s settle into a
distinct pellet on the bottom of the well, and tilting the plate
at a 45◦ angle will result in a teardrop pattern in wells where
the antigen is fully inhibited. The teardrop pattern of each
serum sample should be compared to that of a known anti-
body control diluted using the same method described pre-
viously.
The NVSL employs a slightly diﬀerent version of the HI
test method. U-bottom microtiter plates are used instead
of V-bottom plates [59]. The NDV antigen is added to the
plate, and the serum is diluted directly in the antigen leaving
out the need for PBS in the test wells. The RBC’s are pre-
pared in a 0.5% suspension instead of the 1% suspension
used in the standard method. The serum HI titer for both
methodsisdeterminedbytakingthereciprocalofthehighest
dilution of test serum which is able to completely inhibit
hemagglutination of the RBC’s [1, 2, 12, 30, 58, 59]. Test
serum may cause nonspeciﬁc agglutination of RBC’s so ad-
sorption with chicken RBC’s to remove serum agglutinins
s h o u l db ed o n eo ns e r u mp r i o rt ot e s t i n g .
12.4. Virus Isolation. Virus can usually be isolated from tra-
cheal/oropharyngeal swabs, fecal or cloacal swabs from live
birds, or tissues collected from aﬀected organs of dead birds
[1, 2, 12, 51, 60]. Intestinal tissue and trachea are the most
likely organs to contain virus, but other organs demonstrat-
ing clinical signs could be used for virus isolation. PPMV-1
replicates in the brain causing neurologic symptoms. Brain
tissue may be used for isolation, but it is not recommended
to pool the brain with any other tissue. It is also not recom-
mendedtopooltrachealandfecaltissues[60].Swabsarecol-
lected in viral transport media such as brain heart infusion
(BHI) broth. The swab is swirled to release the viral particles
into the media then wrung out along the inside of the tube
so the swab can be removed prior to transport to the lab. Re-
movaloftheswabpreventsthemediafrombeingabsorbedto
allow for more media available for virus isolation and mole-
cular testing.
Upon arrival in the laboratory, tissues are homogenized
to a 20% weight/volume suspension in antibiotic media such
as BHI broth. Swab media and tissue homogenates are cen-
trifuged to separate the heavier elements from the viralVeterinary Medicine International 11
particles in the supernatant. A portion of the swab superna-
tant is added to an antibiotic mixture and incubated for at
least one hour to eliminate bacterial contamination. The
swab or tissue suspension is then used to inoculate a culture
system such as chicken embryo kidney (CEK) cells, chicken
embryo ﬁbroblast (CEF) cells, or speciﬁc-pathogen-free
(SPF) embryonating chicken eggs [1, 2, 12, 60]. The SPF
chicken egg is the most commonly used culture system.
When SPF eggs are not available, eggs can be used from
ﬂocks that do not have antibodies to NDV. Eggs are incu-
bated 9–11 days at 37◦C prior to inoculation. Four to ﬁve
eggs are inoculated into the allantoic cavity with 0.2mL to
0.3mL of the antibiotic-treated suspension and incubated at
least four days at 37◦Ci nah u m i di n c u b a t o r .I n o c u l a t e de g g s
are examined daily for embryo mortality. The allantoic/am-
niotic ﬂuid (AAF) is harvested from dead embryos on the
same day they die to reduce hemolysis of RBC’s within the
egg. At the end of the incubation period, live embryos are
chilled at 4◦C to kill the embryos and the AAF is harvested.
Presence of live virus in the AAF is determined by the
hemagglutination (HA) test. As previously described, the
hemagglutinin surface glycoprotein of NDV binds RBC’s re-
sulting in hemagglutination. In the HA test PBS is added to
all wells of a microtiter plate and the harvested AAF is serial-
ly diluted twofold across the plate. RBC’s are added and al-
lowed to incubate approximately 30 minutes, and the plate is
tilted to evaluate the wells for the presence or absence of a
teardrop pattern. Wells with a teardrop formation do not
contain any or enough viral antigen to agglutinate the RBC’s.
Wells exhibiting hemagglutination have a diﬀuse red color
throughout the well. This red color is the result of the agglu-
tination of RBC’s and antigen forming a lattice.
Specimens which are not positive for hemagglutinating
virus should be passaged through embryos at least one more
time. Cormorant vNDV does not always demonstrate the
ability to hemagglutinate RBC’s. Replacement of chicken
RBC’s with turkey RBC’s may be beneﬁcial when testing
viral-infected AAF isolated from cormorant species. Even
when turkey RBC’s are utilized, the HA activity of the virus
remainslowmakingtheHAtestunreliableforevaluatingthis
strain of NDV. Bacteria may cause hemagglutination leading
to a false-positive result. Contamination of AAF should be
evaluatedusingaculturemethodsuchas24-hourincubation
on a blood agar plate. Contaminated AAF can be ﬁltered
througha450nmmembraneandpassagedagaininembryos.
Hemagglutinating virus can be evaluated by the HI test
speciﬁc for APMV-1 [1–3, 12, 61]. U-bottom microtiter
plates are set up using a method similar to the one previously
describedforserumspecimens.TheunknownAAFisdiluted
to 4HA units and added to each well in one row of the
plate. A known reference antigen is also added to the wells of
one row. APMV-1-positive polyclonal antibody diluted to a
known concentration is serially diluted twofold in the AAF
across the row. The AAF and antibody are allowed to incu-
batefor30minutesthena0.5%suspensionofRBC’sisadded
to each well. Following an additional 20-minute incubation,
the plate is tilted at a 45◦ angle and evaluated for tear-drop
formation using the same method described previously.
Monoclonal antibodies (mAb) can also be used in the HI test
to identify antigenic groups including PPMV-1, mAb B79
which reacts with almost all NDV except Class I isolates,
other lentogenic mAb (such as AVS-1 and 15C4), and vNDV
(mAb 10D11C) [2, 3, 6, 12, 26, 62]. Additional characteriza-
tion is needed to assess the virulence of the isolate in order to
develop control measures during an outbreak.
12.5. Characterization. Historically three in vivo methods
have been used to determine pathogenicity [2, 3, 12, 30, 63,
64]. These methods include (1) mean death time (MDT) in
embryonating chicken eggs, (2) intravenous pathogenicity
index (IVPI), and (3) ICPI. When performing the MDT pro-
cedure, tenfold serial dilutions of clean AAF are prepared
and each dilution is inoculated into ﬁve 9-to-11-day-old em-
bryonating chicken eggs via the allantoic sac route [65]. The
inoculation time is recorded. A second group is inoculated
in the same manner as the ﬁrst, and the inoculation time is
again recorded. The eggs are incubated at 37◦C and candled
twice a day, once at the beginning of the day and once at the
day’s end. Candling and incubation continues until all em-
bryos die which may require up to seven days. The minimum
lethal dose (MLD) is considered to be the highest dilution
that killed all 5 embryos. The time in hours for all ﬁve em-
bryos to die for each set of the MLD is averaged, giving the
MDT.
The IVPI test requires bacteria-free viral-infected AAF
with an HA titer greater than 1:16 [12, 30, 64]. The AAF is
diluted 1:10 in sterile saline, and 0.1mL is intravenously in-
oculated into 10 six-week-old SPF chickens. Birds are ex-
amined daily for a 10-day period, and each bird is scored ac-
cording to the following observations: 0 if the bird is normal,
1 if the bird demonstrates signs of sickness, 2 if the bird is
severely ill, and 3 if the bird is dead. If a bird is dead, it must
be recorded as 3 for each observation for the remainder of
the 10-day period. The IVPI is calculated as the mean of each
observation for each individual bird over the 10 day period.
The index can range from 0.00 meaning no birds became ill
ordiedovertheobservationperiodto3.00meaningthevirus
killed all 10 birds in the ﬁrst 24 hours after inoculation. ICPI
is the accepted in vivo method of determining pathogenicity
for NDV according to OIE standards [1–3, 12, 30]. As des-
cribed previously an ICPI greater than or equal to 0.7 is one
of the virulence criteria requiring reporting of NDV to the
OIE. Table 1 shows ICPI, MDT, and IVPI pathogenicity in-
dices for 9 well-characterized ND viruses.
Any ICPI value above 0.7 is classiﬁed in the mesogenic to
virulent range [2, 3]. Virulent isolates usually vary from 1.54
to 1.9 (maximum value is 2.0). Cormorant vNDV and
PPMV-1 or vNDV isolates recovered from psittacine birds
can have a highly variable range of ICPI values [2, 3, 6, 26].
These isolates have been shown to have ICPI values from
0.69 to 1.45. These values place them in the mesogenic range
which classiﬁes them as select agents. Additional passages of
these strains of NDV through embryonating chicken eggs
may lead to increased ICPI values indicating adaptation to
poultry over time. Viral tropism for PPMV-1 during chicken
inoculation studies include the heart and brain which is
normally not seen in infected psittacines or from inoculation12 Veterinary Medicine International
with other strains of vNDV [26]. For these reasons psittacine
origin NDV such as PPMV-1 transmission to poultry con-
tinues to be highly concerning.
Velogenic strains of NDV can be classiﬁed as either velo-
genic viscerotropic or velogenic neurotropic based on the re-
sults of the intracloacal inoculation test [3, 28, 63, 66]. The
intracloacal inoculation test also requires bacteria-free viral-
infectedAAFdiluted1:10insterilesaline.Thecloacaoffour
six-to-eight-week-oldSPFchickensareswabbedwiththedil-
uted inoculum. Birds are examined daily for a 10-day period.
Alldeadbirdsarenecropsiedandscoredaccordingtothefol-
lowing observations: +4 when edema of the head and neck,
hemorrhage in the trachea, and hemorrhage and necrosis
throughoutthegastrointestinaltractarepresentand+3to+1
when lesions exist in the respiratory and intestinal tracts but
have decreased severity. Viruses are determined to be vvNDV
if one bird has +4 lesions or at least two birds have +2 to +3
lesions. When birds display neurologic signs prior to death,
the virus is classiﬁed as vnNDV.
The need for trypsin in cell culture media has also been
usedasanindicationofpathogenicity[2,3,6,23,30].Aspre-
viouslydescribed,inorderfortheFproteintobecomeactive,
it must be cleaved by secretory trypsin-like proteases. These
types of proteases are limited to the mucosal membranes in
the respiratory and gastrointestinal tracts. Low virulent
strainsarenotabletoreplicatesystemicallyduetothelimited
availability of these trypsin-like proteases. Virulent strains of
NDV are able to replicate systemically due to the presence of
multiple basic amino acids at the Fusion protein cleavage site
which make it easier to cleave by non-trypsin-like proteases.
This is also true for in vitro analysis where vNDV is able to
replicate and cause plaques in cell culture system lacking
trypsin-like proteases. Low virulent strains are limited in the
cell culture system in which they are able to replicate due to
the lack of trypsin-like proteases. All NDV isolates are able
to replicate in CEK cells likely due to the presence of trypsin-
like proteases. Cell culture systems like CEF and mammalian
cell lines must be supplemented with trypsin-like proteases
or exogenous proteases provided by allantoic ﬂuid, in order
for LoNDV to replicate.
12.6. rRT-PCR. As described in the Section 12.4, classical
diagnostic techniques such as virus isolation and chicken
pathogenicity testing can be time consuming [2, 6, 24, 30,
67]. Rapid diagnostic tests such as rRT-PCR and sequencing
to determine pathogenicity greatly reduce the time required
for implementing control measures. Molecular diagnostic
assays have come a long way from conventional polymerase
chain reaction (PCR) followed by gel electrophoresis for am-
plicon analysis to the current methods of real-time reverse
transcription (rRT) PCR using one-step PCR enzyme kits
[68]. RT-PCR assays provide quick ampliﬁcation helping
them to become essential diagnostic tools for viral detection.
The negative sense nature of the NDV RNA requires reverse
transcriptionintocomplimentaryDNA(cDNA)priortoRT-
PCR ampliﬁcation. Reverse transcription of single-stranded
RNA results in single-stranded cDNA using an RNA-depen-
d e n tD N Ap o l y m e r a s ee n z y m e[ 68, 69]. Advances in enzyme
technology allow both steps to be done in a single tube on
a single PCR instrument. Several rRT-PCR assays have been
developed to detect diﬀerent genes of NDV including the
Matrix, Fusion, and RNA-dependent RNA polymerase.
During rRT-PCR the reverse transcriptase enzyme
becomes activated at around 45◦C initiating reverse trans-
criptionoftheRNAtocDNA[68–70].Theenzymeisallowed
to reverse-transcribe for approximately 10 minutes. When
ample cDNA has been produced, the temperature is brought
up to 95◦C for an additional 10 minutes which causes the re-
versetranscriptasetobecomeinactivated.Afterenzymeinac-
tivation the instrument enters a cycling stage which usually
involves advancing through three temperature settings. The
ﬁrst temperature, usually 94◦C, causes quick denaturing of
the double-stranded cDNA into single-stranded cDNA. The
second step allows for a set of nucleotide primers usually lo-
cated within less than 500 bases of each other along a gene to
anneal to the single-stranded cDNA. One primer binds the
positive sense strand and the other binds the negative sense
strand. In real-time PCR a nucleotide probe also binds to its
target cDNA sequence located somewhere between the two
primer sequences during this step. The temperature of the
second step is determined by the melting temperature of the
less stable primer and the melting temperature of the tem-
plate. The third step is usually at 72◦C, where the polymerase
begins at the primer binding site and copies the cDNA in the
3  to 5  direction along each strand. This results in two sets
of double-stranded cDNA from each original cDNA strand.
These three steps, denaturing, annealing, and ampliﬁcation,
are repeated up to 40 or more times resulting in a doubling
of cDNA during each stage.
When real-time PCR enters this cycling stage, the probe
becomes the indicator of cDNA ampliﬁcation. The TaqMan
probe contains a ﬂuorescent reporter dye, such as 6-carbo-
xyﬂuorescein (FAM), on the 5  end and a quencher, such as
the black-hole quencher, located at the 3  end [68–70]. The
proximity of the quencher to the ﬂuorescent reporter dye re-
duces ﬂuorescence from being released by ﬂuorescence re-
sonance energy transfer (FRET) through space. The poly-
merase moves along the gene extending the primer toward
the site where the probe, is located. When the polymerase
runs into the probe the ﬂuorescent dye is cleaved from the
probe by the 5  exonuclease activity of the Taq polymerase.
Since the ﬂuorescent dye is no longer in close proximity to
the quencher, it is allowed to release ﬂuorescence. The probe
is subsequently cleaved from the target strand, and the poly-
merase copies the remainder of the cDNA strand. The PCR
instrument detects the ﬂuorescence and records the accu-
mulation of ﬂuorescence as the cycling stages progress. The
amount of ﬂuorescence detected is directly proportional to
the amount of ﬂuorophore released during the polymerase
exonuclease activity. This is also directly proportional to the
number of cDNA copies produced during each cycle which
is relayed by the instrument as the cycle threshold (Ct) value.
The Ct value is determined to be the number of PCR cycles
at which exponential increase in cDNA copies is detected by
the release of ﬂuorescence.
Detection methods other than TaqMan probes are avail-
a b l ea n dh a v eb e e nu t i l i z e df o rN D Vr R T - P C Ra s s a y s .Veterinary Medicine International 13
Fluorescent dyes such as SYBR Green or LUX can be used in
RT-PCRassayswithouttheneedforalabeledprobe[71].The
LUXdyeisusedtolabeloneprimerwithasingleﬂuorophore
nearthe3  end.Ahairpinatthe3  endactstoquenchtheﬂu-
orescence which is then released when the primer binds the
template DNA. SYBR Green intercalates into dsDNA, and
ﬂuorescence is released as the dsDNA melts during each RT-
PCR cycle. The amount of ﬂuorescence is proportional to
the concentration of DNA in the sample. Some studies have
used SYBRGreen in conjunction with melt curve analysisfor
diﬀerentiatingvNDVfromLoNDV[72,73].Meltcurveanal-
ysis employs intercalating dyes such as SYBR Green or LUX
ﬂuorogenic primers to measure the change in ﬂuorescence
during each cycle which can then be plotted against the
melting temperature (Tm) [71–73]. Virulent and low viru-
lent strains have diﬀerences in GC content, sequence com-
position, base mismatches, and amplicon length which con-
tribute to the Tm of each strain. The calculated melt curve
canbeusedtodiﬀerentiatebetweenstrains[72,73].Themelt
c u r v em u s ta l s ob ea n a l y z e dt oi d e n t i f yn o n s p e c i ﬁ ca m p l i ﬁ -
cation such as primer dimers.
Beneﬁts of melt curve analysis include primer design and
cost. One set of primers can be used to diﬀerentiate vNDV
fromLoNDVdecreasingtheneedformultipleprimersinone
assay. Costs are lower because expensive ﬂuorescent labeled
probesarenotemployedandmultipleprimersdonothaveto
be purchased. Decrease in sensitivity is a disadvantage of us-
ing intercalating dyes such as SYBR Green [71]. These dyes
are not bound to a probe and therefor have the ability to
intercalate non-speciﬁcally into any dsDNA present such as
primer-dimers or non-target amplicons. Analyzing melting
curves for individual isolates can be subjective. The Tm of
individual isolates may not vary signiﬁcantly and can be dif-
ﬁcult to distinguish between low virulent and highly virulent
strains [72]. TaqMan probes have been used extensively in
rRT-PCR assays for detection and diﬀerentiation of NDV
[4, 7, 11, 13, 29]. These ﬂuorescent labeled probes have the
advantage of binding to speciﬁc regions in the target ampli-
conwhichdecreasestheriskofnonspeciﬁcﬂuorescence.This
type of detection system may require multiple primer sets
and sometimes several diﬀerent TaqMan probes to diﬀeren-
tiate between LoNDV and vNDV strains which can be costly
[72, 73]. Probes may also degrade during their lifespan and
release non-speciﬁc ﬂuorescence [71].
The USDA-validated rRT-PCR assays used at the NVSL
and the NAHLN laboratories detect the M and F genes of
NDV.BothassaysutilizeTaqManprobesandTaq polymerase
enzyme. The M gene assay was designed to detect the highly
conserved matrix gene of most APMV-1, mainly Class II
viruses [4, 6–8]. This assay is used as a screening tool to
detect APMV-1 in diagnostic samples or allantoic ﬂuid from
inoculated embryos. The M gene assay has been highly suc-
cessful for APMV-1 detection including vNDV, cormorant
vNDV, PPMV-1, and most LoNDV. A recent publication by
Kim et al. has shown that the M gene assay failed to detect
73%ofClassIisolatesbetween2004and2007[4,8].Lowvir-
ulent Class I isolates recovered from waterfowl and live bird
marketsintheUScontainedgenomicvariabilityintheprobe
binding site causing loss of probe binding. This lack of
detectioncausessigniﬁcantconcernbecauseofthepossibility
of one of these undetected isolates converting from low viru-
lent to virulent. The possibility of not detecting a new strain
of vNDV could lead to an outbreak and signiﬁcant economic
loss. Development of a new M gene assay with the ability to
detect a broader range of APMV-1 could reduce the possibil-
ity of failing to diagnose a new vND outbreak.
Specimens testing positive by the M gene assay are sub-
sequently tested by the F gene rRT-PCR assay. The F gene
assayisdesignedtoonlydetectvirulentstrainsofAPMV-1by
bindingtheFgenecleavagesite[6,7,67].Thisassaywasvali-
dated during the California END outbreak in 2002-2003 at
the NVSL. Since that time it has been used by the NVSL
and NAHLN laboratories for vND diagnostic testing. Recent
analysis by Kim et al. indicates some PPMV-1 strains are not
detected by the F gene assay [6, 7]. Mismatches in the probe
binding site of some strains of PPMV-1 are also to blame for
the lack of detection of these viruses. Another publication
by Rue et al. indicates the F gene assay is also unable to
detect cormorant vNDV [11]. The inability to detect virulent
strainsofAPMV-1ishighlyconcerningbecauseofthepoten-
tial economic loss an introduction of vND can cause. Even
thoughPPMV-1andcormorantvNDareendemicinpigeons
and cormorants, respectively, detection of any strain of
vNDV is important in the US because either strain may have
the potential to infect poultry. Development of a new F gene
assay able to detect all strains of vNDV would be beneﬁcial
forvNDpassivesurveillanceeﬀortsincludingdiagnostictest-
ingforavianmortalityeventsandforeignanimaldiseasedia-
gnostic investigations.
12.7. Sequencing. DNA sequencing is used in the diagnostic
laboratory to analyze the virulence potential of APMV-1 iso-
lates. Sequencing techniques originated with Sanger et al.
using the dideoxynucleotide triphosphate (ddNTP) medi-
ated chain termination and Maxam et al. using the chemical
degradation method [74–76]. Sequencing techniques have
been rapidly improving since that time, and next-generation
or automated sequencing techniques have become standard
forlaboratoryanalysisofgenesequences.Ingeneralsequenc-
ing occurs as follows; template-speciﬁc primers are used to
amplify cDNA to a high copy number [77]. The ampliﬁed
c D N Ai sa d d e dt oas e c o n dP C Rr e a c t i o nw h e r eD N Ap o l y -
merase extends template-speciﬁc primers by addition of
single-ﬂuorescent ddNTPs. The ﬂuorescence of each ddNTP
addedduringchainextensionisdetectedusinganautomated
sequencing instrument. The position of each nucleotide is
identiﬁed according to the distance from the primer. The
identity of the nucleotide in the DNA chain is identiﬁed by
the individual label of each ddNTP incorporated.
According to the OIE the molecular characteristics of re-
portable virulent NDV include multiple basic amino acids at
thecarboxyl(C-)terminusoftheAPMV-1F2 proteinandthe
presence of phenylalanine at residue 117 of the F1 protein N-
terminus [1–3, 7, 30]. The presence of multiple basic amino
acids allows the F gene of vNDV to be easily cleaved by host
ubiquitous intracellular proteases present throughout the
body [1, 2, 30, 78]. The virus is allowed to replicate14 Veterinary Medicine International
systemically in any host tissue leading to serious disease
development. At the NVSL the presence of multiple basic
amino acids is detected by sequencing a short region of the F
geneencompassingthecleavagesite.Theresultingnucleotide
sequence is converted into an amino acid sequence which is
then analyzed manually to evaluate the amino acids present
directly upstream of the cleavage site.
One or two pairs of basic amino acids, usually lysine (K)
or arginine (R) followed directly by phenylalanine at residue
117,indicateavirulentormesogenicsequence[6,13,29,40].
Consensussequencesforvirulentandmesogenicstrainshave
been determined by Collins et al. to be 112R/K-R-Q-R/K-R-
F117 [3, 13, 40, 79]. Molecular analysis at the F gene cleav-
age site cannot diﬀerentiate mesogenic and virulent strains.
PPMV-1 isolates have been shown to have one of two con-
sensus sequences 112G-R-Q-K-R-F117 or 112R-R-K-K-R-F117
[6,40,79,80].Lowvirulentstrainsusuallyhaveasinglebasic
amino acid followed by a leucine at residue 117. Consensus
sequences for low virulent strains have been determined to
be 112G/E-K/R-Q-G/E-R-L117. Examples of amino acid seq-
uences between positions 112 and 117 of the FO cleavage
site for 9 well-characterized APMV-1 strains are shown in
Table 1.LowvirulentstrainsarecommonlyisolatedintheUS
from wild birds, live bird markets, and poultry vaccinated
with live virus. Fusion gene sequencing analysis is important
to monitor endemic low virulent strains to ensure mutations
are not present which may lead to conversion to virulence.
13. Conclusions
APMV-1 aﬀects all orders of avian species and has a world-
wide distribution. Disease severity is dependent on several
factors including route of inoculation, host species, and
pathogenicity of the virus strain. Virulent strains can cause
great economic loss to the agricultural community. Main-
taining up-to-date diagnostic assays is important for passive
surveillance including mortality events and foreign animal
disease diagnostic investigations. Similarities in clinical
symptoms to other avian diseases and ease of viral transmis-
sion emphasize the need for rapid diagnosis. Classical diag-
nostic methods such as virus isolation can be time consum-
ing leading to a delay in viral identiﬁcation and characteriza-
tion. Molecular methods including rRT-PCR assays and seq-
uencing techniques are rapid methods of identifying and
pathotyping viruses based on their genetic characteristics.
Geneticdiversitycanlimitvalueofmolecularassaysifprimer
design does not keep up with changes in viral sequence over
time.
Small genomic changes resulting from replication errors
can result in alterations in virulence. Introduction of basic
amino acids in the fusion gene cleavage site, for example, can
grant the virus ability to replicate systemically and cause
severe disease. Molecular changes should be monitored to
analyze alterations in the cleavage site which can identify
a potential increase in virulence. Sequencing and rRT-PCR
assays remain important diagnostic tools for monitoring
viral changes. Molecular assays should be continually modi-
ﬁed to maintain the ability to detect all strains of APMV-1.
Diﬀerentiation between virulent and low virulent strains
is also important to recognize and respond to introductions
of virulent viruses into the US. RRT-PCR assays play an im-
portant role in detecting virulent strains of APMV-1. The
ability to detect vND introduction in poultry remains a prio-
rity for diagnostic laboratories. The fusion gene should con-
tinue to be analyzed for development of an rRT-PCR assay
with the ability to detect all strains of vNDV.
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